SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-009011
Filing Date
2021-02-26
Accepted
2021-02-25 18:10:26
Documents
85
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ntla-10k_20201231.htm   iXBRL 10-K 3635429
2 EX-10.21 ntla-ex1021_10.htm EX-10.21 24225
3 EX-21.1 ntla-ex211_6.htm EX-21.1 3516
4 EX-23.1 ntla-ex231_11.htm EX-23.1 4600
5 EX-31.1 ntla-ex311_8.htm EX-31.1 8833
6 EX-31.2 ntla-ex312_7.htm EX-31.2 8725
7 EX-32.1 ntla-ex321_12.htm EX-32.1 7367
8 GRAPHIC g0nonfpqgs3r000002.jpg GRAPHIC 229017
9 GRAPHIC g0nonfpqgs3r000001.jpg GRAPHIC 168876
  Complete submission text file 0001564590-21-009011.txt   13549298

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA ntla-20201231.xsd EX-101.SCH 70472
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntla-20201231_cal.xml EX-101.CAL 55251
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntla-20201231_def.xml EX-101.DEF 231555
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntla-20201231_lab.xml EX-101.LAB 548109
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntla-20201231_pre.xml EX-101.PRE 416464
15 EXTRACTED XBRL INSTANCE DOCUMENT ntla-10k_20201231_htm.xml XML 2588667
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37766 | Film No.: 21682365
SIC: 2835 In Vitro & In Vivo Diagnostic Substances